NRGN and Alzheimer disease: This shift was not present in healthy controls or CU-AP individuals, of which the latter have both plaque and tangle pathology but no cognitive impairment, hence indicating that Ng is a biomarker for AD-related synaptic degeneration that leads to cognitive decline.